Understand the source comparison
SS-31 vs SS-LUP-332 — Mitochondrial Peptides Compared
The difference between SS-31 and SS-LUP-332 comes down to mechanism, not just application. Both peptides target mitochondrial function. But they do so through fundamentally different biological pathways. SS-31 (also called elamipretide or Bendavia) stabilizes
No winner is assigned.
This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.
- The difference between SS-31 and SS-LUP-332 comes down to mechanism, not just application. Both peptides target mitochondrial function. But they do so through fundamentally different biological pathways. SS-31 (also called elamipretide or Bendavia) stabilizes cardiolipin, a phospholipid critical to electron transport chain integrity in the inner mitochondrial membrane. SS-LUP-332, by contrast, functions as a selective PPARδ modulator that activates AMPK (AMP-activated protein kinase), shifting cellular metabolism from glucose storage to fat oxidation. The compounds share a destination but arrive through completely separate routes.
- Our team has sourced both peptides for researchers conducting comparative studies on mitochondrial preservation, metabolic switching, and cellular energy dynamics. What we've observed across lab protocols: SS-31 and SS-LUP-332 are rarely interchangeable. The choice between them depends entirely on whether your research question targets membrane stability or metabolic activation.
- What is the difference between SS-31 and SS-LUP-332?
- SS-31 (elamipretide) is a mitochondria-targeted tetrapeptide that binds to cardiolipin, stabilizing cristae structure and reducing electron leak during oxidative phosphorylation. SS-LUP-332 is a PPARδ agonist that activates AMPK signaling, promoting mitochondrial biogenesis and shifting energy metabolism toward fatty acid oxidation. The difference between SS-31 and SS-LUP-332 lies in their primary mechanism: membrane stabilization versus metabolic pathway activation.
- Here's what that means in practical terms. SS-31 doesn't change how many mitochondria a cell has. It improves the function of existing mitochondria by preventing cardiolipin oxidation, which otherwise leads to cristae disorganization and impaired ATP synthesis. SS-LUP-332, on the other hand, signals the cell to produce more mitochondria and preferentially oxidize fat rather than glucose. One protects what's there; the other builds new capacity and shifts fuel preference. This article covers the structural differences between SS-31 and SS-LUP-332, their divergent mechanisms of action, application-specific advantages in research protocols, and the storage and reconstitution requirements that distinguish peptide handling from small-molecule PPARδ modulators.